Nonaddictive, Nonsedating Pain Medication Shows Promise in Diabetic Neuropathy

TV1001sr stimulates blood vessels with sodium nitrite

Positive results have been reported from a phase 2 study of TV1001sr (TheraVasc, Inc.), an investigational sustained-release, nonaddictive, nonsedating pain medication, for the treatment of patients with pain associated with diabetic neuropathy. The treatment improved pain scores and the neuropathic pain symptom inventory.

Leave a Comment